GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Curatis Holding AG (CHIX:CURNz) » Definitions » Net Interest Income

Curatis Holding AG (CHIX:CURNZ) Net Interest Income : CHF-0.02 Mil (TTM As of Jun. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Curatis Holding AG Net Interest Income?

Net interest income is the total interest income minus total interest expense. It represents the difference between interest and dividends earned on interestbearing assets and interest paid to depositors and other creditors. Curatis Holding AG's net interest income for the six months ended in Jun. 2024 was CHF-0.00 Mil. Its net interest income for the trailing twelve months (TTM) ended in Jun. 2024 was CHF-0.02 Mil.

Curatis Holding AG Net Interest Income Historical Data

The historical data trend for Curatis Holding AG's Net Interest Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curatis Holding AG Net Interest Income Chart

Curatis Holding AG Annual Data
Trend Dec21 Dec22 Dec23
Net Interest Income
-0.01 -0.01 -0.01

Curatis Holding AG Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Net Interest Income Get a 7-Day Free Trial -0.01 - - -0.01 -

Curatis Holding AG Net Interest Income Calculation

Net interest income is the total interest income minus total interest expense. It represents the difference between interest and dividends earned on interestbearing assets and interest paid to depositors and other creditors.

Net Interest Income for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF-0.02 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Curatis Holding AG Net Interest Income Related Terms

Thank you for viewing the detailed overview of Curatis Holding AG's Net Interest Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Curatis Holding AG Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Curatis Holding AG (CHIX:CURNz) » Definitions » Net Interest Income
Comparable Companies
ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD NSE:DIVISLAB HKSE:03692 XSWX:SDZ XTAE:TEVA SHSE:688506 BOM:500087 TSE:4507 SZSE:000538 UTHR NSE:TORNTPHARM BOM:543904 BOM:500124 BOM:500257 NBIX
Traded in Other Exchanges
CURN:Switzerland
Address
Weierweg 7, Liestal, CHE, CH-4410
Website
https://www.curatis.com
Curatis Holding AG is a specialty pharmaceutical company based in Switzerland. It focus on the acquisition, development and commercialisation of medicines for the prevention, diagnosis and treatment of rare and specialty care diseases. Curatis is engaged in two business areas: Distribution business for orphan disease and specialty care medicines and Development business for orphan and specialty care disease medicines. Its product include Aggrastat (Tirofiban), AmbiFul (Fulvestrant), Brinavess (Vernakalant), Coldistop, Cuprior (Trientin), Cyanokit (Hydroxocobalamin), etc.

Curatis Holding AG Headlines

No Headlines